Credit Suisse Ag Alx Oncology Holdings Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Credit Suisse Ag holds 15,765 shares of ALXO stock, worth $16,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,765

Holding current value

$16,395

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$10.95 - $16.79 $172,626 - $264,694	15,765 New	15,765 $175,000
Q1 2023 May 10, 2023	BUY	$4.52 - $11.71 $18 - $46	4 Added 0.02%	21,297 $96,000
Q4 2022 Feb 13, 2023	SELL	$9.51 - $12.95 $46,979 - $63,973	-4,940 Reduced 18.83%	21,293 $239,000
Q3 2022 Nov 10, 2022	BUY	$8.23 - $15.14 $91,155 - $167,690	11,076 Added 73.08%	26,233 $250,000
Q2 2022 Aug 12, 2022	BUY	$5.89 - $19.46 $5,536 - $18,292	940 Added 6.61%	15,157 $121,000
Q1 2022 May 16, 2022	BUY	$13.65 - $22.06 $5,227 - $8,448	383 Added 2.77%	14,217 $240,000
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $203,209 - $703,526	9,456 Added 215.99%	13,834 $297,000
Q3 2021 Nov 12, 2021	BUY	$52.51 - $80.91 $14,230 - $21,926	271 Added 6.6%	4,378 $324,000
Q2 2021 Aug 16, 2021	SELL	$52.2 - $75.23 $105,757 - $152,415	-2,026 Reduced 33.03%	4,107 $224,000
Q1 2021 May 14, 2021	SELL	$62.84 - $87.68 $465,707 - $649,796	-7,411 Reduced 54.72%	6,133 $452,000
Q4 2020 Feb 12, 2021	BUY	$34.11 - $112.26 $461,985 - $1.52 Million	13,544 New	13,544 $1.17 Million

Others Institutions Holding ALXO

# of Institutions

Shares Held

39.5M

Call Options Held

213K

Put Options Held

44.8K

Ven Bio Partners LLC San Francisco, CA

9.7M
Shares

$10.1 Million
13.33% of portfolio
Redmile Group, LLC San Francisco, CA

3.69M
Shares

$3.84 Million
0.48% of portfolio
Tang Capital Management LLC San Diego, CA

3.3M
Shares

$3.43 Million
0.41% of portfolio
Black Rock Inc. New York, NY

2.69M
Shares

$2.8 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.5M
Shares

$2.6 Million
0.0% of portfolio

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $42.4M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account